» Articles » PMID: 21572098

MYCN-regulated MiRNA-92 Inhibits Secretion of the Tumor Suppressor DICKKOPF-3 (DKK3) in Neuroblastoma

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2011 May 17
PMID 21572098
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The MYCN oncogene is frequently amplified in neuroblastoma. It is one of the most consistent markers of bad prognosis for this disease. Dickkopf-3 (DKK3) is a secreted protein of the DKK family of Wnt regulators. It functions as a tumor suppressor in a range of cancers, including neuroblastoma. MYCN was recently found to downregulate DKK3 mRNA. In this study, we show that MYCN knockdown in MYCN-amplified (MNA) neuroblastoma cell lines increases secretion of endogenous DKK3 to the culture media. MicroRNAs (miRNAs) are ∼20 nt long single-stranded RNA molecules that downregulate messenger RNAs by targeting the 3' untranslated region (3'UTR). Many miRNAs regulate genes involved in the pathogenesis of cancer and are extensively deregulated in different tumors. Using miRNA target prediction software, we found several MYCN-regulated miRNAs that could target the 3'UTR sequence of DKK3, including mir-92a, mir-92b and let-7e. Luciferase expression from a reporter vector containing the DKK3-3'UTR was decreased when this construct was cotransfected with mir-92a, mir-92b or let-7e in HEK293 cells. Mutation of the mir-92 seed sequence in the 3'UTR completely rescued the observed decrease in reporter expression when cotransfected with mir-92a and mir-92b. Antagomir and miRNA-mimic transfections in neuroblastoma cell lines confirmed that DKK3 secretion to the culture media is regulated by mir-92. Consistent with reports from other cancers, we found DKK3 to be expressed in the endothelium of primary neuroblastoma samples and to be absent in tumors with MYCN amplification. Our data demonstrate that MYCN-regulated miRNAs are able to modulate the expression of the tumor suppressor DKK3 in neuroblastoma.

Citing Articles

MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma.

Grafals-Ruiz N, Sanchez-Alvarez A, Santana-Rivera Y, Lozada-Delgado E, Rabelo-Fernandez R, Rios-Vicil C Front Oncol. 2023; 13:1249649.

PMID: 37752997 PMC: 10518455. DOI: 10.3389/fonc.2023.1249649.


Deciphering the Role of MicroRNAs in Neuroblastoma.

Veeraraghavan V, Jayaraman S, Rengasamy G, Mony U, Ganapathy D, Geetha R Molecules. 2022; 27(1).

PMID: 35011335 PMC: 8746473. DOI: 10.3390/molecules27010099.


Coupling miR/isomiR and mRNA Expression Signatures Unveils New Molecular Layers of Endometrial Receptivity.

Nikolova M, Naydenov M, Glogovitis I, Apostolov A, Saare M, Boggavarapu N Life (Basel). 2021; 11(12).

PMID: 34947922 PMC: 8705090. DOI: 10.3390/life11121391.


MicroRNA Profiling of HL-1 Cardiac Cells-Derived Extracellular Vesicles.

Silvestro S, Gugliandolo A, Chiricosta L, Diomede F, Trubiani O, Bramanti P Cells. 2021; 10(2).

PMID: 33573156 PMC: 7912193. DOI: 10.3390/cells10020273.


Differential expression of microRNAs in the human fetal left and right cerebral cortex.

Miao N, Lai X, Zeng Z, Cai W, Chen W, Sun T Mol Biol Rep. 2020; 47(9):6573-6586.

PMID: 32808117 DOI: 10.1007/s11033-020-05708-9.